Qi-Xang Li Crown Bioscience Inc. Biography Publications Institution JoVE Articles Qi-Xang Li has not added a biography. If you are Qi-Xang Li and would like to personalize this page please email our Author Liaison for assistance. Publications Anti‑cancer Effects of a Novel Pan‑RAF Inhibitor in a Hepatocellular Carcinoma Cell Line Molecular Medicine Reports. Apr, 2018 | Pubmed ID: 29484394 EGFR Gene Status Predicts Response and Survival Benefit in a Preclinical Gastric Cancer Trial Treating Patient‑derived Xenografts with Cetuximab Oncology Reports. Oct, 2017 | Pubmed ID: 28849161 Experimental Animal Modeling for Immuno-oncology Pharmacology & Therapeutics. May, 2017 | Pubmed ID: 28167217 Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor Molecular Cancer Therapeutics. 04, 2017 | Pubmed ID: 27903750 Molecular Pathology of Patient Tumors, Patient-Derived Xenografts, and Cancer Cell Lines Cancer Research. 08, 2016 | Pubmed ID: 27325646 Design and Synthesis of Novel 3-sulfonylpyrazol-4-amino Pyrimidines As Potent Anaplastic Lymphoma Kinase (ALK) Inhibitors Bioorganic & Medicinal Chemistry Letters. Apr, 2016 | Pubmed ID: 26979157 Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines As Potent Anaplastic Lymphoma Kinase (ALK) Inhibitors Bioorganic & Medicinal Chemistry Letters. Jun, 2015 | Pubmed ID: 26130408 Immunophenotyping di Orthotopic omotrapianto (Syngeneic) dell'Adenocarcinoma Ductal pancreatico murino primario KPC tramite flusso Cytometry Xiaoyu An*1,2, Xuesong Ouyang*1, Hui Zhang1, Tingting Li1, Yu-yang Huang1, Zhiyuan Li1, Demin Zhou2, Qi-Xang Li1,2 1Crown Bioscience Inc., 2State Key Laboratory of Natural and Biomimetic Drugs, Peking University JoVE 57460 Cancer Research
Immunophenotyping di Orthotopic omotrapianto (Syngeneic) dell'Adenocarcinoma Ductal pancreatico murino primario KPC tramite flusso Cytometry Xiaoyu An*1,2, Xuesong Ouyang*1, Hui Zhang1, Tingting Li1, Yu-yang Huang1, Zhiyuan Li1, Demin Zhou2, Qi-Xang Li1,2 1Crown Bioscience Inc., 2State Key Laboratory of Natural and Biomimetic Drugs, Peking University JoVE 57460 Cancer Research